« BackUrologic Oncology: Seminars and Original Investigations
Article in Press

Testicular sparing surgery for small masses

  • Yaniv Shilo, M.D.

      Affiliations

    • Departments of Urology, Assaf Harofeh Medical Center, Zerifin, Israel
    • Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  • ,
  • Amnon Zisman, M.D.

      Affiliations

    • Departments of Urology, Assaf Harofeh Medical Center, Zerifin, Israel
    • Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  • ,
  • Orit Raz, M.D.

      Affiliations

    • Departments of Urology, Assaf Harofeh Medical Center, Zerifin, Israel
    • Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  • ,
  • Erez Lang, M.D.

      Affiliations

    • Departments of Urology, Assaf Harofeh Medical Center, Zerifin, Israel
    • Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  • ,
  • Simon Strauss, M.D.

      Affiliations

    • Diagnostic Imaging, Assaf Harofeh Medical Center, Zerifin, Israel
    • Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  • ,
  • Judith Sandbank, M.D.

      Affiliations

    • Diagnostic Pathology, Assaf Harofeh Medical Center, Zerifin, Israel
    • Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  • ,
  • Michael Segal, M.D.

      Affiliations

    • Diagnostic Pathology, Assaf Harofeh Medical Center, Zerifin, Israel
    • Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  • ,
  • Yoram I. Siegel, M.D.

      Affiliations

    • Departments of Urology, Assaf Harofeh Medical Center, Zerifin, Israel
    • Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  • ,
  • Dan Leibovici, M.D.

      Affiliations

    • Departments of Urology, Assaf Harofeh Medical Center, Zerifin, Israel
    • Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
    • Corresponding Author InformationCorresponding author. Tel.: +972-8-9779409; fax: +972-8-9779402.

Received 8 November 2009; received in revised form 27 December 2009; accepted 28 December 2009. published online 10 May 2010.
Corrected Proof

Abstract 

Objectives

To determine the proportion of benign testicular lesions among candidates for testicular sparing surgery (TSS) and to assess the safety and efficacy of this procedure.

Methods and Materials

Sixteen patients underwent surgical exploration for testicular tumors with TSS intent in our center. Surgery was performed via an inguinal approach with temporary cord occlusion and frozen section (FS) analysis of the lesions. Benign findings allowed for TSS, whereas cancer prompted total orchiectomy.

Results

The lesions measured 8–25 mm in the largest diameter. Eleven of the 16 lesions were benign (69%) and TSS was accomplished in these cases. Complete concordance was observed between the results of FS and permanent sections. Of the 5 patients with cancer, 3 had pure seminoma, and embryonal carcinoma and teratoma were found in 1 patient, each. Surveillance was applied in 4 of these patients, and chemotherapy was used in the patient with embryonal carcinoma. With an average follow-up duration of 48 months, all are alive and free of disease. All 11 patients in whom TSS was accomplished had an uneventful postoperative course, and with an average follow-up duration of 28 months, 9 have normal scrotal physical examination and ultrasound, whereas 2 patients were lost to follow-up.

Conclusions

Sixty-nine percent of testicular lesions under 25 mm are benign. TSS is safe and effective in patients with small benign lesions. Cancer is reliably detected by FS, and testicular exploration is not associated with local or distant recurrence in any of our patients.

Keywords: Testicular sparing surgery, Partial orchiectomy, Benign testicular masses

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1078-1439(09)00431-1

doi:10.1016/j.urolonc.2009.12.021

« BackUrologic Oncology: Seminars and Original Investigations